As authors of the study published as “Cost-Effectiveness of Radiofrequency Denervation for Patients with Chronic Low Back Pain: The MINT Randomized Clinical Trials,” we would like to reply to the Letter to the Editor that was recently written about this study.

First, the authors of the letter state that the analysis was based on only 2 of the 16 centers that were included in the randomized controlled trials (RCTs). This statement is incorrect, and patients from all 16 centers in the RCTs were included for the cost-effectiveness analyses as follows: 252 patients in the facet joint trial, 228 patients in the sacroiliac joint trial, and 202 in the combination group trial.